Evaluation of the BD Phoenix CPO detect panel for prediction of Ambler class carbapenemases

Abstract Rapid detection of carbapenemases as a cause of resistance is beneficial for infection control and antimicrobial therapy. The BD Phoenix NMIC-502 panel and CPO detect test identifies presence of carbapenemases in Enterobacterales such as Klebsiella pneumoniae and assigns them to Ambler clas...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Daniel Jonas, Sandra Reuter, Sarah Klassen, Sabine Weber, Marion Buck, Tommaso Giani, Gian Maria Rossolini, Hajo Grundmann
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/0f024204953a4d4fba9c9687e5e4675f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:0f024204953a4d4fba9c9687e5e4675f
record_format dspace
spelling oai:doaj.org-article:0f024204953a4d4fba9c9687e5e4675f2021-12-02T17:12:18ZEvaluation of the BD Phoenix CPO detect panel for prediction of Ambler class carbapenemases10.1038/s41598-021-92336-32045-2322https://doaj.org/article/0f024204953a4d4fba9c9687e5e4675f2021-06-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-92336-3https://doaj.org/toc/2045-2322Abstract Rapid detection of carbapenemases as a cause of resistance is beneficial for infection control and antimicrobial therapy. The BD Phoenix NMIC-502 panel and CPO detect test identifies presence of carbapenemases in Enterobacterales such as Klebsiella pneumoniae and assigns them to Ambler classes. To evaluate the performance of the CPO detect panel, we employed a European collection of 1222 K. pneumoniae including carbapenem non-susceptible and susceptible clinical isolates from 26 countries, for which draft genomes were available after Illumina sequencing and the presence of carbapenemase genes had been identified by ARIBA gene calling. The CPO panel detected 488 out of 494 carbapenemase-encoding isolates as positive and six as negative. One-hundred and two isolates were tested positive for carbapenemase in the absence of any carbapenemase gene. The CPO panel identified 229 out of 230 KPC-positive isolates as carbapenemase producing and classified 62 of these as class A enzyme. Similarly, the CPO panel correctly specified 167 of 182 as class D. Regarding metallo-beta-lactamases, the CPO panel assigned 78 of 90 MBL positive isolates to class B enzymes. The sensitivity of the CPO panel in detecting carbapenemase activity was 99.5%, 97.7% and 98.3% for class A, B and D enzymes, respectively. The sensitivity in assignation to Ambler class A, B and D was 27%, 86% and 91%, respectively. An overall sensitivity of 98.8% and specificity of 86% in unclassified detection of carbapenemases was observed, with frequent false positive detection of carbapenemase producing organisms, thus rendering further confirmatory tests necessary.Daniel JonasSandra ReuterSarah KlassenSabine WeberMarion BuckTommaso GianiGian Maria RossoliniHajo GrundmannNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Daniel Jonas
Sandra Reuter
Sarah Klassen
Sabine Weber
Marion Buck
Tommaso Giani
Gian Maria Rossolini
Hajo Grundmann
Evaluation of the BD Phoenix CPO detect panel for prediction of Ambler class carbapenemases
description Abstract Rapid detection of carbapenemases as a cause of resistance is beneficial for infection control and antimicrobial therapy. The BD Phoenix NMIC-502 panel and CPO detect test identifies presence of carbapenemases in Enterobacterales such as Klebsiella pneumoniae and assigns them to Ambler classes. To evaluate the performance of the CPO detect panel, we employed a European collection of 1222 K. pneumoniae including carbapenem non-susceptible and susceptible clinical isolates from 26 countries, for which draft genomes were available after Illumina sequencing and the presence of carbapenemase genes had been identified by ARIBA gene calling. The CPO panel detected 488 out of 494 carbapenemase-encoding isolates as positive and six as negative. One-hundred and two isolates were tested positive for carbapenemase in the absence of any carbapenemase gene. The CPO panel identified 229 out of 230 KPC-positive isolates as carbapenemase producing and classified 62 of these as class A enzyme. Similarly, the CPO panel correctly specified 167 of 182 as class D. Regarding metallo-beta-lactamases, the CPO panel assigned 78 of 90 MBL positive isolates to class B enzymes. The sensitivity of the CPO panel in detecting carbapenemase activity was 99.5%, 97.7% and 98.3% for class A, B and D enzymes, respectively. The sensitivity in assignation to Ambler class A, B and D was 27%, 86% and 91%, respectively. An overall sensitivity of 98.8% and specificity of 86% in unclassified detection of carbapenemases was observed, with frequent false positive detection of carbapenemase producing organisms, thus rendering further confirmatory tests necessary.
format article
author Daniel Jonas
Sandra Reuter
Sarah Klassen
Sabine Weber
Marion Buck
Tommaso Giani
Gian Maria Rossolini
Hajo Grundmann
author_facet Daniel Jonas
Sandra Reuter
Sarah Klassen
Sabine Weber
Marion Buck
Tommaso Giani
Gian Maria Rossolini
Hajo Grundmann
author_sort Daniel Jonas
title Evaluation of the BD Phoenix CPO detect panel for prediction of Ambler class carbapenemases
title_short Evaluation of the BD Phoenix CPO detect panel for prediction of Ambler class carbapenemases
title_full Evaluation of the BD Phoenix CPO detect panel for prediction of Ambler class carbapenemases
title_fullStr Evaluation of the BD Phoenix CPO detect panel for prediction of Ambler class carbapenemases
title_full_unstemmed Evaluation of the BD Phoenix CPO detect panel for prediction of Ambler class carbapenemases
title_sort evaluation of the bd phoenix cpo detect panel for prediction of ambler class carbapenemases
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/0f024204953a4d4fba9c9687e5e4675f
work_keys_str_mv AT danieljonas evaluationofthebdphoenixcpodetectpanelforpredictionofamblerclasscarbapenemases
AT sandrareuter evaluationofthebdphoenixcpodetectpanelforpredictionofamblerclasscarbapenemases
AT sarahklassen evaluationofthebdphoenixcpodetectpanelforpredictionofamblerclasscarbapenemases
AT sabineweber evaluationofthebdphoenixcpodetectpanelforpredictionofamblerclasscarbapenemases
AT marionbuck evaluationofthebdphoenixcpodetectpanelforpredictionofamblerclasscarbapenemases
AT tommasogiani evaluationofthebdphoenixcpodetectpanelforpredictionofamblerclasscarbapenemases
AT gianmariarossolini evaluationofthebdphoenixcpodetectpanelforpredictionofamblerclasscarbapenemases
AT hajogrundmann evaluationofthebdphoenixcpodetectpanelforpredictionofamblerclasscarbapenemases
_version_ 1718381419590320128